Want to see CRVL full AI Analyst Report?
CorVel (CRVL) AI Stock Analysis
CorVel
(NASDAQ:CRVL)
Strong financial performance with consistent growth and low-leverage balance sheet, combined with positive technical momentum above moving averages, are the primary drivers; favorable corporate governance support adds to the score, while premium valuation tempers the overall result.
CorVel Key Performance Indicators (KPIs)
Revenue by Service LineBreaks down sales across CorVel’s business lines (claims administration, bill review, network and specialty services), showing which areas drive growth and profits. A shift toward higher‑margin or rapidly growing services indicates better future earnings power, while concentration in one line increases vulnerability to pricing pressure, regulatory changes, or competitive loss.
Network Solutions is the clear growth engine, accelerating on CERIS and large payer wins with bookings and prepaid realization that should lift revenue and operating leverage as multiyear implementations scale; Patient Management is stable but only low single‑digit growth, so near‑term upside depends on converting pipeline into scaled deployments and the touted AI/automation efficiency gains to normalize elevated staffing and turn timing benefits into sustainable margin improvement.
The FlyCorVel (CRVL) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $4.15B
- Dividend Yield
- ―
- Average Volume (3M)
- 185.21K
- Price to Earnings (P/E)
- 36.5
- Beta (1Y)
- 0.49
- Revenue Growth
- 7.09%
- EPS Growth
- 14.95%
- Country
- US
- Employees
- 5,239
- Sector
- General
- Sector Strength
- 55
- Industry
- Insurance - Brokers
CorVel Business Overview & Revenue Model
Company Description
CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims. The company focuses on controlling medical expenditu...
How the Company Makes Money
CorVel makes money by charging customers (such as employers, insurance companies, and third-party administrators) fees for delivering healthcare and claims-related management services and for access to its technology-enabled workflows. Key revenue st...
CorVel Earnings Call Summary
The call presented multiple strong operational and financial positives: revenue and EPS growth (quarterly and fiscal), improved margins, robust new bookings (+56%) and pipeline expansion (RFPs +20%), cash generation, a debt-free balance sheet and aggressive share repurchases. Strategic wins for CERIS, expansion of prepaid solutions and continued AI/automation investments position the company for scalable growth. Offset risks include a higher effective tax rate, some one-time/timing-driven CERIS benefits that may not fully recur, only low single-digit growth in patient management, near-term staffing costs, and industry headwinds including rising claims severity and cybersecurity risks. Overall, the favorable results, expanding bookings and strong cash/return-of-capital program materially outweigh the noted challenges.
Q4-2026 Updates
Positive Updates
Negative Updates
Company Guidance
The company guided that momentum from CERIS and recently signed enterprise programs—4 large payer implementations in 2026, including 2 new multiyear partnerships with top‑10 national payers—should drive ongoing revenue and profit tailwinds, with new bookings up 56% year‑over‑year and RFP activity up 20%, and those multiyear bookings expected to contribute meaningfully to revenue and profit growth in the back half of the calendar year as implementations scale; management also said a timing‑related CERIS benefit added $0.02 to EPS in the period. They expect prepaid solutions (revenue realization in about 1–2 months versus ~6+ months for postpaid) and expanded automation/AI to deliver sustained productivity gains, normalize elevated personnel levels as deployments mature, reduce manual work and improve operating leverage through the remainder of the year and into 2027. Supporting this push, CorVel pointed to a strong, debt‑free balance sheet with $233M cash, $66M free cash flow for FY2026, and ongoing share repurchases (872,744 shares repurchased for $56M in FY2026; 366,306 for $20M in Q4; 115.3M total repurchased to date for $868M, ~69% of shares outstanding at an average $7.70), which management said funds continued investment in technology, product expansion and M&A optionality.
CorVel Financial Statement Overview
Summary
Robust financials with steady revenue growth to $984M TTM, improving margins, strong equity growth to $409M, low debt-to-equity of 0.05, and solid operating cash flow of $151M TTM.
Income Statement
85Very PositiveBalance Sheet
90Very PositiveCash Flow
82Very Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 983.74M | 958.53M | 895.59M | 795.31M | 718.56M | 646.23M |
| Gross Profit | 235.13M | 232.86M | 209.73M | 171.69M | 158.26M | 152.11M |
| EBITDA | 184.13M | 174.90M | 150.36M | 121.35M | 109.67M | 108.43M |
| Net Income | 115.33M | 110.34M | 95.17M | 76.25M | 66.36M | 66.41M |
Balance Sheet | ||||||
| Total Assets | 689.74M | 642.99M | 545.98M | 454.68M | 393.92M | 415.25M |
| Cash, Cash Equivalents and Short-Term Investments | 255.88M | 233.07M | 170.58M | 105.56M | 71.33M | 97.50M |
| Total Debt | 28.39M | 28.11M | 28.08M | 31.40M | 33.76M | 43.14M |
| Total Liabilities | 280.84M | 248.75M | 223.99M | 207.03M | 191.75M | 202.85M |
| Stockholders Equity | 408.89M | 394.23M | 321.99M | 247.65M | 202.18M | 212.40M |
Cash Flow | ||||||
| Free Cash Flow | 113.82M | 110.28M | 91.56M | 70.00M | 55.97M | 37.40M |
| Operating Cash Flow | 150.55M | 155.64M | 127.31M | 99.24M | 82.29M | 67.22M |
| Investing Cash Flow | -36.73M | -45.36M | -35.76M | -29.24M | -26.32M | -29.82M |
| Financing Cash Flow | -59.96M | -47.80M | -26.54M | -35.76M | -82.14M | -79.61M |
CorVel Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CRVL, the sentiment is Positive. The current price of 83.48 is above the 20-day moving average (MA) of 80.08, above the 50-day MA of 74.71, and above the 200-day MA of 62.48, indicating a bullish trend. The MACD of 2.51 indicates Positive momentum. The RSI at 65.69 is Neutral, neither overbought nor oversold. The STOCH value of 48.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CRVL.
CorVel Risk Analysis
CorVel disclosed 32 risk factors in its most recent earnings report. CorVel reported the most risks in the "Tech & Innovation" category.
Latest Risks Added
0 New RisksCorVel Peers Comparison
Overall Rating
- CRVL79Outperform
AJG78Outperform
AON76Outperform
WTW73Outperform
BRO71Outperform
CRD.A65Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| CRVL | 79Outperform | $4.15B | 36.54 | 29.93% | ― | 7.09% | 14.95% |
| AJG | 78Outperform | $70.76B | 41.77 | 7.16% | 1.00% | 25.60% | 3.46% |
| AON | 76Outperform | $68.24B | 17.52 | 40.38% | 1.00% | 3.29% | 46.05% |
| WTW | 73Outperform | $29.92B | 19.71 | 19.92% | 1.17% | 4.75% | -22.03% |
| BRO | 71Outperform | $23.14B | 19.06 | 9.69% | 0.95% | 26.10% | 8.89% |
| CRD.A | 65Neutral | $572.58M | 25.39 | 13.01% | 2.50% | -4.12% | -20.24% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CRVL | Corvel | 82.22 | 6.16 | 8.10% | |
| AON | Aon Plc | 321.67 | -20.12 | -5.89% | |
| AJG | Arthur J. Gallagher | 276.07 | 27.30 | 10.97% | |
| BRO | Brown & Brown | 69.76 | -8.47 | -10.83% | |
| CRD.A | Crawford & Company A | 12.19 | 1.45 | 13.53% | |
| WTW | Willis Towers Watson Public Limited Company | 324.42 | 5.80 | 1.82% |
CorVel Corporate Events
CorVel Shareholders Back Board, Auditor and Executive Pay
PositiveAt its annual meeting of stockholders held on August 6, 2026, CorVel Corporation shareholders elected six directors to serve until the 2027 annual meeting or until their successors are chosen. The voting results showed broad support for most nominees...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 06, 2026